AbbVie Inks $24M Deal With Calif. Regulators In Humira Case
AbbVie Inc. has agreed to shell out $24 million and reform the marketing of its arthritis drug Humira in California to resolve a state Department of Insurance suit accusing the company...To view the full article, register now.
Already a subscriber? Click here to view full article